About Us

Our goal is to produce the Inactivated Polio Vaccine (IPV) based on serum free Vero Cell technology. With our annual capacity of 200 million doses we want to contribute to the global effort of final polio eradication. Our plan is to reconstruct the existing manufacturing site and start GMP production of validation batches in 2019. The manufacturing site as well as our final product will fulfil the most stringent quality and safety requirements.